Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged ≥65 years - PubMed (original) (raw)

Kevin A Matthews et al. Alzheimers Dement. 2019 Jan.

Abstract

Introduction: Alzheimer's disease and related dementias (ADRD) cause a high burden of morbidity and mortality in the United States. Age, race, and ethnicity are important risk factors for ADRD.

Methods: We estimated the future US burden of ADRD by age, sex, and race and ethnicity by applying subgroup-specific prevalence among Medicare Fee-for-Service beneficiaries aged ≥65 years in 2014 to subgroup-specific population estimates for 2014 and population projection data from the United States Census Bureau for 2015 to 2060.

Results: The burden of ADRD in 2014 was an estimated 5.0 million adults aged ≥65 years or 1.6% of the population, and there are significant disparities in ADRD prevalence among population subgroups defined by race and ethnicity. ADRD burden will double to 3.3% by 2060 when 13.9 million Americans are projected to have the disease.

Discussion: These estimates can be used to guide planning and interventions related to caring for the ADRD population and supporting caregivers.

Keywords: Alzheimer's disease; Dementia; Estimates; Prevalence; Projections; Race and ethnicity.

Published by Elsevier Inc.

PubMed Disclaimer

Figures

Fig. 1.

Fig. 1.

Estimated prevalence of Alzheimer’s disease and related dementias in the US Population aged ≥65 years, by sex and race and ethnicity; United States, 2014.

Fig. 2.

Fig. 2.

Estimated prevalence of Alzheimer’s disease and related dementias in the US Population aged ≥65 years, by age and race and ethnicity; United States, 2014.

Fig. 3.

Fig. 3.

Projected number of adults aged ≥65 years with Alzheimer’s disease and related dementias for all groups (A), and by sex (B), age (C), and race and ethnicity (D); 2015 to 2060. Abbreviations: ADRD, Alzheimer’s disease and related dementia; AIAN, American Indian or Alaska Native; NH-White, Non-Hispanic white; PI, Pacific Islander.

Similar articles

Cited by

References

    1. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 2016; 12:459–509. - PubMed
    1. Brookmeyer R, Evans DA, Hebert L, Langa KM, Heeringa SG, Plassman BL, et al. National estimates of the prevalence of Alzheimer’s disease in the United States. Alzheimers Dement 2011; 7:61–73. - PMC - PubMed
    1. Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology 2013;80:1778–83. - PMC - PubMed
    1. Rocca WA, Petersen RC, Knopman DS, Hebert LE, Evans DA, Hall KS, et al. Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States. Alzheimers Dement 2011;7:80–93. - PMC - PubMed
    1. Brookmeyer R, Abdalla N, Kawas CH, Corrada MM. Forecasting the prevalence of preclinical and clinical Alzheimer’s disease in the United States. Alzheimer’s Demen 2018;14:121–9. - PMC - PubMed

MeSH terms

LinkOut - more resources